All News #Library
Rare Diseases
Calliditas Reports Data On Setanaxib In Alport Syndrome at ASN
11 Nov 2025 //
PR NEWSWIRE
Calliditas announces an seven year orphan drug exclusivity period for TARPEYO®
06 Mar 2024 //
PR NEWSWIRE

Market Place
Sourcing Support